Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$8,770 Mln
Revenue (TTM)
$12,669 Mln
Net Profit (TTM)
$0 Mln
ROE
0.1 %
ROCE
6.2 %
P/E Ratio
22.4
P/B Ratio
2.6
Industry P/E
64.27
EV/EBITDA
12.7
Div. Yield
0 %
Debt to Equity
0.6
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
121,720,000
CFO
$6,089.60 Mln
EBITDA
$9,856.52 Mln
Net Profit
$4,903.68 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Henry Schein (HSIC)
| 5.7 | 13.0 | -6.0 | -2.0 | -4.1 | 5.1 | 2.8 |
|
BSE Sensex*
| 4.3 | 3.9 | 7.7 | 10.3 | 14.5 | 21.5 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Henry Schein (HSIC)
| -8.5 | -5.2 | 3.0 | 16.0 | 0.2 | 8.4 | 12.3 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Henry Schein (HSIC)
|
73.1 | 8,769.9 | 12,669.0 | 407.0 | 5.4 | 11.8 | 22.4 | 2.6 |
| 13.5 | 9,103.9 | 6,685.2 | 715.6 | 16.4 | 12.3 | 12.8 | 1.5 | |
| 250.1 | 7,142.0 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 1.0 | |
| 247.1 | 6,694.4 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 1.0 | |
| 38.2 | 5,727.9 | 3,446.1 | 79.6 | 7.5 | 4.4 | 72.7 | 3.1 | |
| 61.6 | 8,264.9 | 2,510.8 | 185.6 | 8.8 | 4.5 | 45.6 | 2.0 | |
| 156.2 | 8,437.6 | 1,973.6 | -494.5 | -11.4 | -41 | -- | 8.8 | |
| 98.8 | 5,840.8 | 1,387.9 | 122.3 | 13.3 | 8.9 | 48.4 | 4.1 | |
| 281.1 | 10,903.7 | 1,240.1 | 42.2 | 4.1 | 3.6 | 263.1 | 9.0 | |
| 127.6 | 7,089.8 | 645.7 | -25.4 | 6.8 | -1.3 | -- | 3.6 |
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and... Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins. It also provides financial services on a nonrecourse basis, education services for practitioners, consulting, and other services; and consumable merchandise under its own brand. In addition, the company manufactures, markets, and sells dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. Further, it is involved in the development and distribution of practice management software, e-services, and other products to health care providers. The company serves customers in dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York. Address: 135 Duryea Road, Melville, NY, United States, 11747 Read more
Executive Chairman & CEO
Mr. Stanley M. Bergman
Senior VP & CFO
Mr. Ronald N. South
Headquarters
Melville, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Henry Schein Inc (HSIC) stood at $ 13,397 Mln as on 31-Mar-25
The share price of Henry Schein Inc (HSIC) is $73.13 (NASDAQ) as of 20-May-2025 16:00 EDT. Henry Schein Inc (HSIC) has given a return of -4.08% in the last 3 years.
Henry Schein Inc (HSIC) has a market capitalisation of $ 8,770 Mln as on 19-May-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Henry Schein Inc (HSIC) is 2.65 times as on 19-May-2025, a 26% discount to its peers’ median range of 3.56 times.
The P/E ratio of Henry Schein Inc (HSIC) is 22.45 times as on 19-May-2025, a 65% discount to its peers’ median range of 64.27 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Henry Schein Inc (HSIC) and enter the required number of quantities and click on buy to purchase the shares of Henry Schein Inc (HSIC).
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins. It also provides financial services on a nonrecourse basis, education services for practitioners, consulting, and other services; and consumable merchandise under its own brand. In addition, the company manufactures, markets, and sells dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. Further, it is involved in the development and distribution of practice management software, e-services, and other products to health care providers. The company serves customers in dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York. Address: 135 Duryea Road, Melville, NY, United States, 11747
The CEO & director of Mr. Stanley M. Bergman. is Henry Schein Inc (HSIC), and CFO & Sr. VP is Mr. Ronald N. South.
There is no promoter pledging in Henry Schein Inc (HSIC).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,119
|
|
|
876
|
|
|
830
|
|
|
787
|
|
|
719
|
|
|
687
|
|
|
687
|
|
|
573
|
|
|
558
|
| Henry Schein Inc. (HSIC) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Henry Schein Inc (HSIC) was $0 Mln.
$1.29
(
